IRIS
COSTANTINI, AMBRA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 111
NA - Nord America 76
AS - Asia 71
OC - Oceania 1
Totale 259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 76
SE - Svezia 49
CN - Cina 41
SG - Singapore 26
IT - Italia 21
NL - Olanda 16
RU - Federazione Russa 12
IN - India 3
LT - Lituania 3
BE - Belgio 2
DE - Germania 2
GB - Regno Unito 2
AU - Australia 1
FI - Finlandia 1
FR - Francia 1
IE - Irlanda 1
PL - Polonia 1
TR - Turchia 1
Totale 259
Salva come PNG Salva come JPEG
Città #
Shanghai 26
Ashburn 18
Singapore 15
Lawrence 11
Princeton 11
Meppel 10
Moscow 7
Rome 4
Guangzhou 3
Amsterdam 2
Boardman 2
Brussels 2
Mumbai 2
Shenzhen 2
Bologna 1
Buffalo 1
Castelmoron-sur-Lot 1
Dublin 1
Frankfurt am Main 1
Jiaxing 1
Los Angeles 1
Milan 1
New Albany 1
Pontedera 1
Pune 1
Santa Clara 1
St. George 1
Sydney 1
Taizhou 1
Xi'an 1
Totale 131
Salva come PNG Salva come JPEG
Nome #
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 35
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 25
Erratum: Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV (BMC infectious diseases (2021) 21 1 (557)) 19
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 19
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 17
On-clamp versus off-clamp partial nephrectomy: Propensity score-matched comparison of long-term functional outcomes 17
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 17
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV 17
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy 16
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 16
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial 16
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 14
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 14
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 13
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 10
Outcomes of treatment for achalasia depend on manometric subtype 7
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 6
Pneumatic dilation versus laparoscopic heller's myotomy for idiopathic achalasia 5
Botulinum toxin injection vs laparoscopic myotomy for the treatment of esophageal achalasia: Economic analysis of a randomized trial 4
Randomized Controlled Trial of Botulinum Toxin Versus Laparoscopic Heller Myotomy for Esophageal Achalasia 3
Totale 290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 2 0 2 1 1 0 0 0 0
2021/20228 0 0 0 1 0 0 0 6 0 0 0 1
2022/202393 23 22 7 1 1 11 4 11 12 1 0 0
2023/202483 4 2 6 23 10 7 10 9 0 2 4 6
2024/202599 32 8 9 9 17 24 0 0 0 0 0 0
Totale 290